These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12100777)

  • 1. Right ballpark, wrong base: assessing safety of NSAIDs.
    Shaughnessy AF
    J Fam Pract; 2002 Jun; 51(6):538. PubMed ID: 12100777
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current EULAR data on valdecoxib. New study results of gastrointestinal safety and "cost effectiveness"].
    Kellner H
    Krankenpfl J; 2004; 42(5-6):185. PubMed ID: 15527245
    [No Abstract]   [Full Text] [Related]  

  • 3. The COX-2 inhibitors--an update.
    Furberg CD
    Am Heart J; 2006 Aug; 152(2):197-9. PubMed ID: 16875896
    [No Abstract]   [Full Text] [Related]  

  • 4. [Coxib instead of NSAID plus gastric acid inhibitor. Protection for the small intestine].
    MMW Fortschr Med; 2004 Mar; 146(13):61. PubMed ID: 15219139
    [No Abstract]   [Full Text] [Related]  

  • 5. [Progress in therapy of rheumatism. New coxib works especially fast].
    MMW Fortschr Med; 2003 Jun; 145(23):58. PubMed ID: 12854230
    [No Abstract]   [Full Text] [Related]  

  • 6. The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus.
    Sowers JR; White WB; Pitt B; Whelton A; Simon LS; Winer N; Kivitz A; van Ingen H; Brabant T; Fort JG;
    Arch Intern Med; 2005 Jan; 165(2):161-8. PubMed ID: 15668361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adverse effects of NSAID are insidious. No pain--despite life threatening gastric hemorrhage].
    MMW Fortschr Med; 2002 Sep; 144(37):55. PubMed ID: 12380342
    [No Abstract]   [Full Text] [Related]  

  • 8. Selective COX-2 inhibition.
    Silas S; Clegg DO
    Bull Rheum Dis; 1999; 48(2):1-4. PubMed ID: 12024416
    [No Abstract]   [Full Text] [Related]  

  • 9. Valdecoxib (Bextra)--a new cox-2 inhibitor.
    Med Lett Drugs Ther; 2002 Apr; 44(1129):39-40. PubMed ID: 11981510
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pain therapy in rheumatism. After 65 years of age coxibs are the best choice].
    MMW Fortschr Med; 2003 Oct; 145(42):60. PubMed ID: 14655447
    [No Abstract]   [Full Text] [Related]  

  • 11. [Selective cox-2 inhibitors. Better tolerance than NSAID plus antacid].
    MMW Fortschr Med; 2004 Apr; 146(15):66. PubMed ID: 15373027
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy of arthrosis. Life threatening gastrointestinal events can be reduced].
    MMW Fortschr Med; 2001 Jun; 143(23):34-5. PubMed ID: 11460416
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug safety. FDA panel urges caution on many anti-inflammatory drugs.
    Couzin J
    Science; 2005 Feb; 307(5713):1183-5. PubMed ID: 15731414
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclooxygenase (COX-2) selective inhibitors. Any better than NSAIDs?
    Nguyen A; Chaiton A
    Can Fam Physician; 2001 Jul; 47():1398-400. PubMed ID: 11494927
    [No Abstract]   [Full Text] [Related]  

  • 15. [Specific cyclo-oxygenase inhibitors. 2. Gastric toxicity?].
    Blondon H
    Presse Med; 2000 Mar; 29(9):482-3. PubMed ID: 10745938
    [No Abstract]   [Full Text] [Related]  

  • 16. Valdecoxib is associated with improved dyspepsia-related health compared with nonspecific NSAIDs in patients with osteoarthritis or rheumatoid arthritis.
    Rabeneck L; Goldstein JL; Vu A; Mayne TJ; Rublee DA
    Am J Gastroenterol; 2005 May; 100(5):1043-50. PubMed ID: 15842577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Selective Cox-2 inhibitor in osteoarthritis and rheumatoid arthritis. No increased risk for the heart].
    MMW Fortschr Med; 2003 Mar; 145(11):60. PubMed ID: 12688204
    [No Abstract]   [Full Text] [Related]  

  • 18. Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study.
    Singh G; Fort JG; Goldstein JL; Levy RA; Hanrahan PS; Bello AE; Andrade-Ortega L; Wallemark C; Agrawal NM; Eisen GM; Stenson WF; Triadafilopoulos G;
    Am J Med; 2006 Mar; 119(3):255-66. PubMed ID: 16490472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The future of peptic ulcer disease without Helicobacter].
    Lehmann FS; Gyr N
    Praxis (Bern 1994); 2003 Mar; 92(12):547-50. PubMed ID: 12693146
    [No Abstract]   [Full Text] [Related]  

  • 20. [Adverse effect-free analgesia. New COX-2 inhibitor is even more selective].
    MMW Fortschr Med; 2003 May; 145(18):54. PubMed ID: 12808824
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.